1. Home
  2. COEP vs NMTC Comparison

COEP vs NMTC Comparison

Compare COEP & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • NMTC
  • Stock Information
  • Founded
  • COEP 2017
  • NMTC 2009
  • Country
  • COEP United States
  • NMTC United States
  • Employees
  • COEP N/A
  • NMTC N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • NMTC Medical/Dental Instruments
  • Sector
  • COEP Health Care
  • NMTC Health Care
  • Exchange
  • COEP Nasdaq
  • NMTC Nasdaq
  • Market Cap
  • COEP 27.4M
  • NMTC 33.8M
  • IPO Year
  • COEP N/A
  • NMTC N/A
  • Fundamental
  • Price
  • COEP $9.14
  • NMTC $0.72
  • Analyst Decision
  • COEP
  • NMTC Strong Buy
  • Analyst Count
  • COEP 0
  • NMTC 1
  • Target Price
  • COEP N/A
  • NMTC $1.45
  • AVG Volume (30 Days)
  • COEP 34.5K
  • NMTC 180.3K
  • Earning Date
  • COEP 08-15-2025
  • NMTC 08-13-2025
  • Dividend Yield
  • COEP N/A
  • NMTC N/A
  • EPS Growth
  • COEP N/A
  • NMTC N/A
  • EPS
  • COEP N/A
  • NMTC N/A
  • Revenue
  • COEP $62,874.00
  • NMTC $5,758,777.00
  • Revenue This Year
  • COEP N/A
  • NMTC $141.04
  • Revenue Next Year
  • COEP N/A
  • NMTC $38.86
  • P/E Ratio
  • COEP N/A
  • NMTC N/A
  • Revenue Growth
  • COEP N/A
  • NMTC 54.53
  • 52 Week Low
  • COEP $2.31
  • NMTC $0.40
  • 52 Week High
  • COEP $13.70
  • NMTC $1.39
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.60
  • NMTC 63.09
  • Support Level
  • COEP $7.25
  • NMTC $0.68
  • Resistance Level
  • COEP $8.86
  • NMTC $0.77
  • Average True Range (ATR)
  • COEP 0.69
  • NMTC 0.05
  • MACD
  • COEP 0.15
  • NMTC 0.01
  • Stochastic Oscillator
  • COEP 75.48
  • NMTC 73.64

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Share on Social Networks: